Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pramodini MedicareNSE:PRAMODINI -2.01%19 PS Ratio is 14.19 as of Aug. 31, 2026, which is 1% below its 10-year median of 14.39. GuruFocus rates NSE:PRAMODINI with a GF Score™ of 19/100. The stock has 1 warning sign investors should review. Among 664 Healthcare Providers & Services companies, Pramodini Medicare ranks worse than 95.03% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Pramodini Medicare's share price is ₹114.80.
Pramodini Medicare's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹8.09. Hence, Pramodini Medicare's PS Ratio for today is 14.19.
The historical rank and industry rank for Pramodini Medicare's PS Ratio or its related term are showing as below:
NSE:PRAMODINI'
s PS Ratio Range Over the Past 10 Years
Min: 14.19 Med: 14.39 Max: 14.59
Current: 14.19
During the past 4 years, Pramodini Medicare's highest PS Ratio was 14.59. The lowest was 14.19. And the median was 14.39.
NSE:PRAMODINI's PS Ratio is ranked worse than 95.03% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 1.53
vs NSE:PRAMODINI: 14.19
During the past 4 years, Pramodini Medicare's highest 3-Year average Revenue per Share Growth Rate was 26.80% per year. The lowest was 26.80% per year. And the median was 26.80% per year.
Pramodini Medicare (NSE:PRAMODINI) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Pramodini Medicare PS Ratio Related Terms
Pramodini Medicare PS Ratio Historical Data
* Premium members only.
The historical data trend for Pramodini Medicare's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pramodini Medicare PS Ratio Chart
Pramodini Medicare Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
PS Ratio
0.00
0.00
0.00
0.00
Pramodini Medicare Quarterly Data
Mar23
Mar24
Mar25
Dec25
Mar26
PS Ratio
0.00
0.00
0.00
0.00
0.00
NSE:PRAMODINI vs HCA, THC, EHC: PS Ratio Comparison
For the Medical Care Facilities subindustry, Pramodini Medicare's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pramodini Medicare PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pramodini Medicare's PS Ratio distribution charts can be found below:
* The bar in red indicates where Pramodini Medicare's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Pramodini Medicare's Share Price of today is ₹114.80. Pramodini Medicare's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹8.09.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Pramodini Medicare (NSE:PRAMODINI) has a PS Ratio of 14.19 as of Aug. 31, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Pramodini Medicare and its competitors. This is near median its historical median of 14.39. Over the past decade, Pramodini Medicare's PS Ratio has ranged from 14.19 to 14.59. According to the industry distribution chart, Pramodini Medicare ranks #631 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 95%.
Is Pramodini Medicare's PS Ratio too high?
Pramodini Medicare's current PS Ratio of 14.19 is near median its 10-year median of 14.39. Over the past 10 years, this metric has ranged from a low of 14.19 to a high of 14.59. The Healthcare Providers & Services industry median PS Ratio is 1.53. Pramodini Medicare's value of 14.19 is 827.5% above this industry median. Based on the distribution chart, Pramodini Medicare ranks #631 out of 664 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Pramodini Medicare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Pramodini Medicare's PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Pramodini Medicare ranks #631 out of 664 companies for PS Ratio. This places Pramodini Medicare in the lower half of its industry. The industry median PS Ratio is 1.53. Pramodini Medicare's value of 14.19 is 827.5% above this benchmark. Historically, Pramodini Medicare's own PS Ratio has ranged from 14.19 to 14.59 over the past decade. While the company's 10-year median is 14.39 vs. the industry median of 1.53, Pramodini Medicare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.53, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pramodini Medicare's current PS Ratio of 14.19 is 827.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Pramodini Medicare and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pramodini Medicare's current PS Ratio is 14.19, which is near median its own 10-year median of 14.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pramodini Medicare stock overvalued right now?
Pramodini Medicare (NSE:PRAMODINI) has a current PS Ratio of 14.19. The current PS Ratio is 14.19, which is near median its 10-year median of 14.39 and 827.5% above the Healthcare Providers & Services industry median of 1.53. Pramodini Medicare's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Pramodini Medicare (NSE:PRAMODINI), the current PS Ratio is 14.19 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pramodini Medicare Ltd is a diagnostic service provider in India. It provides a range of technology-enabled diagnostic services such as radiology, clinical laboratory and nuclear medicine service to public hospitals, private hospitals, certain PSU (Public Sector Undertaking) of Government of India and medical colleges across tier I, tier II and tier III cities throughout India. The company also provide teleradiology services, which functions on a 24*7 basis throughout the year. It provides healthcare services for core testing, patients diagnosis, disease prevention and monitoring of various health conditions. Its services includes both routine and specialized tests, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases.
19GF Score
Get the complete analysis for NSE:PRAMODINI
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:PRAMODINI has been successfully added to your 
